Latest

Manipal University College Malaysia welcomes the Hon’ble Shri Narendra Modi, Prime Minister of India, on his official visit to Malaysia

Friday, 06 Feb 2026 5:00PM

MELAKA, Malaysia, Feb 6 (Bernama) -- Manipal University College Malaysia (MUCM), part of the Ma...

See More
MALAYSIA HEALTHCARE STRENGTHENS BILATERAL RELATIONS WITH CAMBODIA THROUGH DIPLOMATIC ENGAGEMENT

Friday, 06 Feb 2026 4:26PM

 <a href="nteprimages/20260206_643690.jpg" target="_blank"><img bo...

See More

Other Press Release

NX Vietnam Launches Consolidation Service On Vietnam's North-south Railway

Friday, 07 Feb 2025 12:00AM

TOKYO, Feb. 7, 2025 /Kyodo JBN/ --- Offering Efficient, Sustainable Low-emission Logistics Service f...

See More
AKWEL: 2024 &#24180;&#23454;&#29616;&#33829;&#19994;&#39069; 9.89 &#20159;&#27431;&#20803;

Friday, 07 Feb 2025 12:00AM

尚弗罗米耶,Feb 7 (Bernama-GLOBE NEWSWIRE) --2024 年&...

See More
Salience Labs Closed Series A Round Led By Applied Ventures And ICM HPQC Fund

Friday, 07 Feb 2025 12:00AM

Image by Shabbir BasharAppointment of Dr. William Jeffrey to the Board and Bonnie Tomei as CFOOXFORD...

See More
MyGAS 2025: Tackling Financing Challenges In The Gas Industry

Friday, 07 Feb 2025 12:00AM

MyGAS 2025:  Tackling Financing Challenges in the Gas IndustryKUALA LUMPUR, Feb 7 (Bernama) -- ...

See More
KLCCP Stapled Group Caps 2024 With A Strong RM459.1 Million Revenue In Quarter Four

Thursday, 06 Feb 2025 12:00AM

KUALA LUMPUR, Feb 6 (Bernama) -- KLCCP Stapled Group delivered a strong performance in quarter four,...

See More
Uni-Fuels Announces Sponsorship For IBIA Annual Dinner 2025

Thursday, 06 Feb 2025 12:00AM

SINGAPORE, Feb 6 (Bernama-GLOBE NEWSWIRE) -- Uni-Fuels Holdings Limited (NASDAQ: UFG), (&l...

See More
Guangdong Advances Industrial Modernization To Enhance Global Competitiveness

Thursday, 06 Feb 2025 12:00AM

CPC Guangdong Committee’s Secretary Huang Kunming delivers a speech at the provincial high-qua...

See More
Zenas BioPharma Announces Key 2024 Accomplishments And 2025 Business Objectives To Support The Global Development And Commercialization Of Therapies For Autoimmune Diseases

Thursday, 06 Feb 2025 12:00AM

- Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B ...

See More